|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4985 | |
| A61K 31/5383 | |||
| A61K 31/519 | |||
| A61P 25/28 | |||
| A61P 25/18 | |||
| A61P 25/24 | |||
| A61P 25/00 | |||
| A61K 45/06 | |||
| C07D 471/14 |
| (11) | Patento numeris | 3407889 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17771285.8 |
| Europos patento paraiškos padavimo data | 2017-03-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/024137 |
| Data | 2017-03-24 |
| (87) | Numeris | WO 2017/165843 |
| Data | 2017-09-28 |
| (30) | Numeris | Data | Šalis |
| 201662313629 P | 2016-03-25 | US |
| (72) |
YAO, Wei, US
LI, Peng, US
|
| (73) |
Intra-Cellular Therapies, Inc.,
430 East 29th Street, Suite 900, New York, NY 10016,
US
|
| (54) | ORGANIC COMPOUNDS AND THEIR USE IN TREATING OR PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS |
| ORGANIC COMPOUNDS AND THEIR USE IN TREATING OR PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS |